The current valuation score of Ginkgo Bioworks Holdings Inc is 6.84, ranking 291 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.94, which is -84.73% below the recent high of -0.30 and -121.95% above the recent low of -4.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.